Regional Variation across Canadian Centers in Radioiodine Administration for Thyroid Remnant Ablation in Well-Differentiated Thyroid Cancer Diagnosed in 2000–2010
Table 3
Total number of patients with well-differentiated thyroid cancer by stage and center.
Center
TNM stage
Total
T1
T2
T3
T4
N1a/N1b
N0/Nx
N1a/N1b
N0/Nx
N1a/N1b
N0/Nx
N1a/N1b
N0/Nx
London
84 (5)
496 (29)
48 (29)
300 (18)
136 (8)
176 (10)
16 (0.9)
8 (0.5%)
1264
Halifax
21 (9)
144 (64)
3 (1)
31 (14)
7 (3)
17 (8)
1 (0.4)
0 (0)
224
Winnipeg
56 (6)
355 (38)
45 (5)
223 (24)
80 (9)
138 (15)
27 (3)
12 (0.3)
936
Toronto
19 (5)
167 (47)
7 (2)
102 (29)
6 (2)
49 (14)
2 (0.6)
1 (0.3)
353
St. John’s
11 (7)
52 (44)
2 (1)
32 (21)
6 (4)
46 (30)
2 (1)
1 (0.7)
152
Hamilton
12 (10)
40 (44)
9 (8)
15 (13)
9 (8)
13 (11)
6 (5)
1 (0.9)
105
Fredericton
4 (11)
15 (40)
1 (3)
11 (29)
0 (0)
7 (16)
0 (0)
0 (0)
38
Data are presented as n (%), with the percentage referring to fraction of patients per center. Percentage values are rounded to the nearest number, unless <1%. There were no major differences between centers.
